117 related articles for article (PubMed ID: 8339388)
1. Human autopsy-tissue distribution of menogaril and its metabolites.
Stewart DJ; Grewaal D; Green RM; Goel R; Mikhael N; Montpetit VA; Redmond D; Earhart R
Cancer Chemother Pharmacol; 1993; 32(5):373-8. PubMed ID: 8339388
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and disposition of menogaril (NSC 269148) in the rabbit.
Dodion P; Egorin MJ; Engisch KL; Bachur NR
Cancer Res; 1985 Nov; 45(11 Pt 1):5352-7. PubMed ID: 2932217
[TBL] [Abstract][Full Text] [Related]
3. Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide.
Stewart DJ; Grewaal D; Redmond MD; Mikhael NZ; Montpetit VA; Goel R; Green RM
Cancer Chemother Pharmacol; 1993; 32(5):368-72. PubMed ID: 8339387
[TBL] [Abstract][Full Text] [Related]
4. A phase I clinical and pharmacokinetic study of the oral and the oral/intravenous administration of menogaril.
Weiss GR; Brown TD; Kuhn JG; Von Hoff DD; Earhart RH; Adams WJ; Brewer JE; Hosley JD; Kasunic DA
Invest New Drugs; 1993 Feb; 11(1):17-27. PubMed ID: 8349432
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues.
Stewart DJ; Grewaal D; Green RM; Mikhael N; Goel R; Montpetit VA; Redmond MD
Anticancer Res; 1993; 13(6A):1945-52. PubMed ID: 8297100
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Dodion P; Sanders C; Rombaut W; Rozencweig M; Kitt MM; Kenis Y; Klastersky J
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):245-9. PubMed ID: 2940092
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the optimum clinical dosing schedule for menogaril from results with tumor-bearing mice.
Yoshida M; Kobunai T; Nakano K; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(5A):2869-73. PubMed ID: 8917400
[TBL] [Abstract][Full Text] [Related]
9. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
Egorin MJ; Conley BA; Forrest A; Zuhowski EG; Sinibaldi V; Van Echo DA
Cancer Res; 1987 Nov; 47(22):6104-10. PubMed ID: 2959359
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and acute cardiovascular effects of menogaril in patients with metastatic tumors.
Piergies AA; Benson AB
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):63-9. PubMed ID: 7757312
[TBL] [Abstract][Full Text] [Related]
11. Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
Long HJ; Powis G; Schutt AJ; Moertel CG
Cancer Treat Rep; 1987 Jun; 71(6):593-8. PubMed ID: 2953414
[TBL] [Abstract][Full Text] [Related]
12. Human autopsy tissue concentrations of mitoxantrone.
Stewart DJ; Green RM; Mikhael NZ; Montpetit V; Thibault M; Maroun JA
Cancer Treat Rep; 1986 Nov; 70(11):1255-61. PubMed ID: 3768871
[TBL] [Abstract][Full Text] [Related]
13. Concentration of vinblastine in human intracerebral tumor and other tissues.
Stewart DJ; Lu K; Benjamin RS; Leavens ME; Luna M; Yap HY; Loo TL
J Neurooncol; 1983; 1(2):139-44. PubMed ID: 6678966
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
[TBL] [Abstract][Full Text] [Related]
15. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Egorin MJ; Van Echo DA; Whitacre MY; Forrest A; Sigman LM; Engisch KL; Aisner J
Cancer Res; 1986 Mar; 46(3):1513-20. PubMed ID: 2935249
[TBL] [Abstract][Full Text] [Related]
16. The disposition of the new anthracycline antibiotic, menogarol, in mice.
Dodion P; Chang BK; Egorin MJ; Olman EA; Engisch KL; Bachur NR
Drug Metab Dispos; 1984; 12(3):365-70. PubMed ID: 6145565
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of intravenous menogaril administered intermittently.
Dodion P; Sessa C; Joss R; Crespeigne N; Willems Y; Kitt M; Abrams J; Finet C; Brewer JE; Adams WJ
J Clin Oncol; 1986 May; 4(5):767-74. PubMed ID: 2939203
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of menogaril in patients with advanced cancer.
Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
[TBL] [Abstract][Full Text] [Related]
19. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
[TBL] [Abstract][Full Text] [Related]
20. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues.
Brien JF; Jimmo S; Brennan FJ; Ford SE; Armstrong PW
Can J Physiol Pharmacol; 1987 Mar; 65(3):360-4. PubMed ID: 3580958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
